Discussing personalized prognosis in amyotrophic lateral sclerosis: development of a communication guide

Remko M van Eenennaam, Willeke J Kruithof, Michael A van Es, Esther T Kruitwagen-van Reenen, Henk-Jan Westeneng, Johanna M A Visser-Meily, Leonard H van den Berg, Anita Beelen

Research output: Contribution to journalArticleAcademicpeer-review

5 Downloads (Pure)

Abstract

BACKGROUND: Personalized ENCALS survival prediction model reliably estimates the personalized prognosis of patients with amyotrophic lateral sclerosis. Concerns were raised on discussing personalized prognosis without causing anxiety and destroying hope. Tailoring communication to patient readiness and patient needs mediates the impact of prognostic disclosure. We developed a communication guide to support physicians in discussing personalized prognosis tailored to individual needs and preferences of people with ALS and their families.

METHODS: A multidisciplinary working group of neurologists, rehabilitation physicians, and healthcare researchers A) identified relevant topics for guidance, B) conducted a systematic review on needs of patients regarding prognostic discussion in life-limiting disease, C) drafted recommendations based on evidence and expert opinion, and refined and finalized these recommendations in consensus rounds, based on feedback of an expert advisory panel (patients, family member, ethicist, and spiritual counsellor).

RESULTS: A) Topics identified for guidance were 1) filling in the ENCALS survival model, and interpreting outcomes and uncertainty, and 2) tailoring discussion to individual needs and preferences of patients (information needs, role and needs of family, severe cognitive impairment or frontotemporal dementia, and non-western patients). B) 17 studies were included in the systematic review. C) Consensus procedures on drafted recommendations focused on selection of outcomes, uncertainty about estimated survival, culturally sensitive communication, and lack of decisional capacity. Recommendations for discussing the prognosis include the following: discuss prognosis based on the prognostic groups and their median survival, or, if more precise information is desired, on the interquartile range of the survival probability. Investigate needs and preferences of the patients and their families for prognostic disclosure, regardless of cultural background. If the patient does not want to know their prognosis, with patient permission discuss the prognosis with their family. If the patient is judged to lack decisional capacity, ask the family if they want to discuss the prognosis. Tailor prognostic disclosure step by step, discuss it in terms of time range, and emphasize uncertainty of individual survival time.

CONCLUSION: This communication guide supports physicians in tailoring discussion of personalized prognosis to the individual needs and preferences of people with ALS and their families.

Original languageEnglish
Article number446
Pages (from-to)1-11
JournalBMC Neurology
Volume20
Issue number1
DOIs
Publication statusPublished - 14 Dec 2020

Keywords

  • Amyotrophic lateral sclerosis
  • Communication guide
  • Personalized prognosis
  • Physician-patient communication
  • Prognosis
  • Truth disclosure

Fingerprint

Dive into the research topics of 'Discussing personalized prognosis in amyotrophic lateral sclerosis: development of a communication guide'. Together they form a unique fingerprint.

Cite this